California Liver Research Institute

Recent papers from California Liver Research Institute

1. Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b studyThe Lancet · 2025
2. Association Between Pruritus and Healthcare Utilization and Costs Among Individuals With Primary Biliary CholangitisLiver international communications. · 2026
3. Efficacy and safety of belapectin for the prevention of esophageal varices in patients with MASH cirrhosis: The randomized, placebo-controlled NAVIGATE trial.2026
4. Clinical Characteristics of Metabolic Dysfunction Steatotic Liver Disease in Asian-American Patients with Chronic Hepatitis BJournal of Immigrant and Minority Health · 2026
5. Europa Clipper Mission Design: Interplanetary Trajectory Mission AnalysisThe Journal of the Astronautical Sciences · 2026
6. Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forwardExpert Review of Gastroenterology & Hepatology · 2026
7. HMG-CoA Reductase Inhibitors (Statins) May Preserve Hepatic Function and Reduce Portal-Systemic Shunting in Compensated Advanced Chronic Liver Disease: Results From the SHUNT-V StudyClinical and Translational Gastroenterology · 2026
8. α-Diversity analysis of hepatic transcriptome reveals distinct pathways in alcohol-associated hepatitisJCI Insight · 2026
9. Screening Patients for Elevated Left Ventricular End‐Diastolic Pressure Using a Novel Noninvasive Brachial Cuff–ECG System: A Multicenter Validation StudyJournal of the American Heart Association · 2025
10. Association between elevations in alkaline phosphatase and healthcare utilization and costs among individuals with primary biliary cholangitis in the United StatesJournal of Medical Economics · 2025
11. Alkaline phosphatase changes with seladelpar across subgroups of primary biliary cholangitis patients in the response trialZeitschrift für Gastroenterologie · 2025
12. Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer AggressivenessJournal of Proteome Research · 2025
13. Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of RemyelinationACS Chemical Neuroscience · 2025
14. Automated Integration and Quality Assessment of Chromatographic Peaks in LC–MS-Based Metabolomics and Lipidomics Using TARDISAnalytical Chemistry · 2025
15. AI portal tract detection and characterisation for a regional analysis of steatosis and inflammation in MASLD, MASH, and AIH2025
16. Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapyWorld Journal of Gastrointestinal Pathophysiology · 2024
17. Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B StudyClinical and Translational Gastroenterology · 2024
18. Severe acute liver disease in adults: Contemporary role of histopathologyHistopathology · 2024
19. Effects of Mediterranean Diet During Pregnancy on the Onset of Overweight or Obesity in the Offspring: A Randomized Trial2024
20. Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitisAlimentary Pharmacology & Therapeutics · 2023